VIA
GRCL

Vident Investment Advisory’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Vident Investment Advisory’s Portfolio GRCL Stock Details GRCL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$38.4K Hold
2022
Q3 		$54K Sell
2022
Q2 		$110K Hold
2022
Q1 		$47K Buy
2021
Q4 		$76K Sell
2021
Q3 		$228K Buy